Area: Cardiology
Location: Paris, France
Date: August 31 to September 4
Description:
European Society of Cardiology.
CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study
SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry
ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study
PURE: Impact of modifiable risk factors on cardiovascular disease and mortality
RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.
POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial
Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease
AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease
GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial
Salt substitution and community-wide reduction in blood pressure and hypertension incidence
HOPE 4 - Impact on cardiovascular risk of a community based multifaceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study
SYNTAXES: Ten-Year Survival after Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention: The SYNTAX Extended Survival study
MITRA-FR - 2 years follow-Up of the MITRA-FR study a randomized controlled trial evaluating the effectiveness of percutaneous mitral valve repair in secondary mitral regurgitation
DAPA HF The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure Trial
CONDI-2/ERIC-PPCI Effect of remote ischemic conditioning on clinical outcomes in patients with Stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention
RAPID‑TnT ‑ A randomised trial of a 1‑hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T
POPular Genetics - Genotype- guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infraction undergoing primary PCI: a randomized, open-label, multicenter trial
Long-term outcome of the Defibrillator After Primary Angioplasty Trial - Implantable Defibrillator Early After Primary Percutaneous Intervention for ST- Elevation Myocardial infraction
ENTRUST‑AF PCI ‑ Edoxaban‑based versus vitamin‑K‑ antagonist‑based anti‑thrombotic regimen following successful coronary stenting in atrial fibrillation patients
Differences in the management and outcomes in congenital versus acquired heart disease
ESC Congress Highlights
Late Breaking Science in Cardiovascular Pharmacology
PURE Study
The CLARIFY study
Controversies in secondary prevention: treating residual risk
ESC 2019 Guidelines
How wider use of combinations will improve control of the main cardiovascular risk factors
Lipid and Blood pressure lowering
HOPE 4 ‑ Impact on cardiovascular risk of a community‑based multi‑faceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study
Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?